Abivax (ABVX) Interest & Investment Income (2024 - 2026)
Abivax (ABVX) posted quarterly Interest & Investment Income of $14.9 million for Q1 2026, up 815.0% year-over-year from $1.6 million in Q1 2025, and up 167.23% quarter-over-quarter from $5.6 million in Q4 2025.
Abivax (ABVX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Abivax's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $14.9 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 815.0% year-over-year to $14.9 million; the TTM figure through Mar 2026 stood at $48.3 million (up 262.41% YoY), while the FY2025 annual figure was $32.1 million, up 118.51% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $14.9 million, up from $5.6 million in the prior quarter.
- The five-year high for Interest & Investment Income was $23.9 million in Q3 2025, with the low at $1.6 million in Q1 2025.
- The 3-year median for Interest & Investment Income is $4.0 million (2024), against an average of $7.6 million.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income sank 75.08% in 2025, then soared 815.0% in 2026.
- Abivax's Interest & Investment Income stood at $4.0 million in 2024, then jumped by 38.27% to $5.6 million in 2025, then surged by 167.23% to $14.9 million in 2026.
- Business Quant data shows ABVX's Interest & Investment Income at $14.9 million in Q1 2026, $5.6 million in Q4 2025, and $23.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | 14.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.94 Mn |
| Dec 31, 2025 | 5.59 Mn |
| Sep 30, 2025 | 23.85 Mn |
| Jun 30, 2025 | 3.96 Mn |
| Mar 31, 2025 | 1.63 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 3.77 Mn |
| Jun 30, 2024 | 3.89 Mn |
| Mar 31, 2024 | 6.55 Mn |